Earnings Beat for Teva – Analyst Blog

By | November 2, 2012
0 Comment

Teva Pharmaceutical Industries ‘ ( TEVA ) third quarter earnings of $1.28 per American Depositary Share (ADS) were 3 cents above the Zacks Consensus Estimate and 2% above the year-ago

More:
Earnings Beat for Teva – Analyst Blog

Related posts:

  1. Harman's Q1 Earnings Beat Impressive – Analyst Blog
  2. Facebook 2Q Earnings Beat Estimate – Analyst Blog
  3. Verizon Q3 Earnings Beat Estimates – Analyst Blog
  4. Beat and Raise Quarter for Amgen – Analyst Blog